Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Calgary

$105,000.00

The kaposin gene cluster drives KSHV latent and lytic infection cycles and viral tumourigenesis

FY 2020-21

Summary
Viruses are estimated to account for 12-20% of cancer cases worldwide. As a cancer-causing virus replicates, it co-opts cellular machinery that would normally be used to detect and resolve dangerous pre-cancerous events. Without the use of this machinery, cells can divide unchecked and cancer may develop. My project addresses a major knowledge gap for one of the seven human cancer-causing viruses, Kaposi's Sarcoma-associated Herpesvirus (KSHV). KSHV is the cause of Kaposi's Sarcoma (KS), an unusual skin cancer which develops from the unrestricted growth of cells that line our blood vessels. When KSHV infects these cells, it can adopt either a dormant (latent) or active (lytic) life cycle, both of which are important for cancer development. During these lifecycles, a set of three proteins, known as kaposin proteins, are produced by virus-infected cells. Very atypically for a herpesvirus, the kaposin proteins are made in both the dormant and active viral lifecycles. The role of these proteins however, and the cellular machinery they may co-opt, is not fully understood. My goal is to determine what role(s) the kaposins have in viral infection and in cancer development. To achieve my goal, I have developed an important set of tools for the KSHV field that will now permit us to study these poorly characterized kaposins: a set of KSHV viruses deficient in kaposin protein production yet otherwise, normal. By studying KSHV using my toolbox of kaposin-deficient viruses, I will learn how these proteins are important to both lifecycles of the virus and how they contribute to tumour development. In doing so, we expect KSHV to act as a homing beacon to help us identify key molecules involved in tumour development. Completion of this project will therefore lead to novel therapeutic targets for KS, and cancer therapy in general.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
439647
Name
Kleer Mariel
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The kaposin gene cluster drives KSHV latent and lytic infection cycles and viral tumourigenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Molecular Biology; Viral-Tumourigenesis; Virology
Abstract
Viruses are estimated to account for 12-20% of cancer cases worldwide. As a cancer-causing virus replicates, it co-opts cellular machinery that would normally be used to detect and resolve dangerous pre-cancerous events. Without the use of this machinery, cells can divide unchecked and cancer may develop. My project addresses a major knowledge gap for one of the seven human cancer-causing viruses, Kaposi's Sarcoma-associated Herpesvirus (KSHV). KSHV is the cause of Kaposi's Sarcoma (KS), an unusual skin cancer which develops from the unrestricted growth of cells that line our blood vessels. When KSHV infects these cells, it can adopt either a dormant (latent) or active (lytic) life cycle, both of which are important for cancer development. During these lifecycles, a set of three proteins, known as kaposin proteins, are produced by virus-infected cells. Very atypically for a herpesvirus, the kaposin proteins are made in both the dormant and active viral lifecycles. The role of these proteins however, and the cellular machinery they may co-opt, is not fully understood. My goal is to determine what role(s) the kaposins have in viral infection and in cancer development. To achieve my goal, I have developed an important set of tools for the KSHV field that will now permit us to study these poorly characterized kaposins: a set of KSHV viruses deficient in kaposin protein production yet otherwise, normal. By studying KSHV using my toolbox of kaposin-deficient viruses, I will learn how these proteins are important to both lifecycles of the virus and how they contribute to tumour development. In doing so, we expect KSHV to act as a homing beacon to help us identify key molecules involved in tumour development. Completion of this project will therefore lead to novel therapeutic targets for KS, and cancer therapy in general.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kleer, Mariel
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
University of Calgary - $105,000 Grant (2020-21) | Canada Spends